Stimulant Use Disorder

This information is useful for children, adults, and older adults
drug abuse
Why Yale Medicine?
  • Our clinicians offer a range of behavioral therapies for people with stimulant use disorder.
  • If eligible, patients can enroll in clinical trials that use the latest techniques to treat drug addiction.
  • Our physicians and staff offer a support and encouragement for patients facing their addiction.

Coke, crack, meth, speed. Those are some shorthand terms for different types of stimulants that belong to a highly addictive class of drugs frequently used in the United States. Stimulants increase alertness, attention and energy while also elevating blood pressure, heart rate and breathing. While stimulants such as Adderall and Ritalin are legally prescribed for conditions such as attention deficit hyperactivity disorder (ADHD), recreational versions such as cocaine and methamphetamine are illegal. 

Excessive and non-medical use of those drugs can be dangerous, and sometimes deadly. Doctors and researchers at Yale Medicine are leading the field in developing behavioral therapies to help people with stimulant use disorder stop taking those drugs. From reward-based methods to internet-based approaches, Yale Medicine is creating and enhancing treatments for stimulant users and often offering clinical trials for participants.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.